Secondary prevention medications for cardiovascular diseases (CVD) are underused globally and additional strategies to increase their use are needed to improve CVD management and reduce premature mortality rates, according to a study published in the Journal of the American College of Cardiology.
This article was originally published on MedicalXpress.com